Oncogenic NTRK3 mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemia.

Joshi SK, Huang A, Pittsenbarger J, Shinde U, Posso C, Piehowski PD, Gosline SJC, Press RD, Gritsenko MA, Hutchinson C, Weitz KK, Watanabe-Smith K, Long N, Rodland KD, Tyner JW, Druker BJ, Tognon CE

Open source

DOI: 10.3324/haematol.2024.285572
Published: 2025 Jul 1
Container: Haematologica
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2024.285572,
  title = {Oncogenic NTRK3 mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemia.},
  author = {Joshi SK and Huang A and Pittsenbarger J and Shinde U and Posso C and Piehowski PD and Gosline SJC and Press RD and Gritsenko MA and Hutchinson C and Weitz KK and Watanabe-Smith K and Long N and Rodland KD and Tyner JW and Druker BJ and Tognon CE},
  year = {2025},
  journal = {Haematologica},
  doi = {10.3324/haematol.2024.285572},
  url = {https://doi.org/10.3324/haematol.2024.285572}
}

RIS

TY  - JOUR
TI  - Oncogenic NTRK3 mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemia.
AU  - Joshi SK
AU  - Huang A
AU  - Pittsenbarger J
AU  - Shinde U
AU  - Posso C
AU  - Piehowski PD
AU  - Gosline SJC
AU  - Press RD
AU  - Gritsenko MA
AU  - Hutchinson C
AU  - Weitz KK
AU  - Watanabe-Smith K
AU  - Long N
AU  - Rodland KD
AU  - Tyner JW
AU  - Druker BJ
AU  - Tognon CE
PY  - 2025
JO  - Haematologica
DO  - 10.3324/haematol.2024.285572
UR  - https://doi.org/10.3324/haematol.2024.285572
ER  -

APA

SK, J., A, H., J, P., U, S., C, P., PD, P., SJC, G., RD, P., MA, G., C, H., KK, W., K, W., N, L., KD, R., JW, T., BJ, D., & CE, T. (2025). Oncogenic NTRK3 mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemia.. Haematologica. https://doi.org/10.3324/haematol.2024.285572

Source records

pubmed · retrieved 2026-09-26T13:58:30.305Z
europe-pmc · retrieved 2026-09-26T13:58:30.293Z
doaj · retrieved 2026-09-26T13:58:30.264Z